Automated Breast Ultrasound Systems (ABUS) Market Possible Product Scope, Market Overview and growth Forecast to 2028

Automated Breast Ultrasound System (ABUS) are used for obtaining 3D ultrasound images of breast for diagnosis of cancer tissue.

SEATTLE, WASHINGTON, UNITED STATES, January 19, 2022 /EINPresswire.com/ -- New Research Study "Automated Breast Ultrasound Systems (ABUS) Market 2022 analysis by Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges and Investment Opportunities), Size, Share and Outlook" has been added to Coherent Market Insights.

Automated breast ultrasound (ABUS) is an operator independent system that obtains three dimensional (3D) high resolution images. The system is time-efficient and has similar sensitivity, cancer detection rate, diagnostic accuracy rates and image quality compared to hand-held ultrasound.

𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐰𝐢𝐭𝐡 𝐋𝐚𝐭𝐞𝐬𝐭 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 @ https://www.coherentmarketinsights.com/insight/request-sample/78

Statistics:

The global automated breast ultrasound system (ABUS) market is estimated to account for US$ 275.1 Mn in terms of value and 1,270 units in terms of volume by the end of 2027.

Global Automated Breast Ultrasound System (ABUS) Market: Drivers

Increasing adoption of FDA-approved ABUS is expected to boost growth of the global automated breast ultrasound system (ABUS) market over the forecast period. For instance, in August 2019, St. Mary’s Women’s Imaging, Oklahoma (U.S) launched the InveniaTM ABUS 2.0.

Global Automated Breast Ultrasound System (ABUS) Market: Opportunities

Increasing research and development of enhanced imaging techniques is expected to create lucrative growth opportunities for players operating in the global automated breast ultrasound system (ABUS) market. For instance, in July 2019, researchers from Acıbadem Mehmet Ali Aydınlar University School of Medicine, Turkey, reported comparison of ABUS reading time of a breast radiologist to a radiology resident independent of the clinical outcomes, in a research published in the European Journal of Breast Health.

Global Automated Breast Ultrasound System (ABUS) Market: Market Restraints

Codes associated with ABUS are complex. Therefore, lack of trained professional is expected to hinder growth of the market.

Key Takeaways:

The North America region held dominant position in the global automated breast ultrasound system (ABUS) market in 2018, accounting for 41.6% share in terms of value, followed by Europe and Asia Pacific, respectively. The growth of the market is attributed to increasing technological advancement and increasing focus towards women health during the forecast period.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞 𝐰𝐢𝐭𝐡 𝐋𝐚𝐭𝐞𝐬𝐭 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 @ https://www.coherentmarketinsights.com/insight/request-pdf/78

Market Trends

The increasing number of breast imaging centers is expected to facilitate the market growth. For instance, in February 2019, QTbreasthealth started a breast imaging center in San Jose, California. Moreover, key players in the market are focused on implementing advanced technologies. For instance, in February 2019, QT Ultrasound created the first 3D printing of the breast duct system in a living woman using QTscan.

Global Automated Breast Ultrasound System (ABUS) Market: Competitive Landscape

Major players operating in the global automated breast ultrasound system (ABUS) market are General Electric Co., Siemens AG, Hitachi Ltd., QT Ultrasound LLC, Ikonopedia, and SonoCiné Inc.

Global Automated Breast Ultrasound System (ABUS) Market: Key Developments

Key players in the market are focused on obtaining product approval and launching new products to expand their offerings. For instance, in October 2018, QT Ultrasound LLC’s QT Scanner 2000 Model A received ‘breakthrough device designation’ from the U.S FDA. Key players in the market are focused on partnership strategies to expand their product portfolio. For instance, in August 2019, Terason Ultrasound, an ultrasound imaging company, and DiA Imaging Analysis, a provider of AI-based solutions for ultrasound analysis, signed a partnership deal, under which DiA Imaging Analysis will offer its cardiac solutions in Terason's point-of-care ultrasound devices.

For More Information or Query or Customization before Buying, Visit at – https://www.coherentmarketinsights.com/insight/talk-to-analyst/78

Segmentation:

Automated Breast Ultrasound System (ABUS) Market, By Region:

North America

By Country:

U.S.

Canada

Latin America

By Country:

Brazil

Mexico

Argentina

Rest of Latin America

Europe

By Country:

Germany

U.K.

France

Italy

Spain

Russia

Rest of Europe

Asia Pacific

By Country:

China

India

Japan

Australia

South Korea

ASEAN

Rest of Asia Pacific

Middle East

By Country:

GCC

Israel

Rest of Middle East

Africa

By Country/Sub-region:

South Africa

Central Africa

North Africa

Company Profiles

General Electric Co.*

Company Overview

Product Portfolio

Key Highlights

Financial Overview

Strategies

Siemens AG

Hitachi Ltd.

QT Ultrasound LLC

Ikonopedia

SonoCiné Inc.

𝗕𝘂𝘆 𝗡𝗼𝘄 𝗔𝗻𝗱 𝗚𝗲𝘁 𝗙𝗹𝗮𝘁 𝗨𝗦𝗗 𝟮𝟬𝟬𝟬 𝗢𝗙𝗙

𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐓𝐡𝐢𝐬 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐩𝐨𝐫𝐭 𝐓𝐨 𝐀𝐜𝐜𝐞𝐬𝐬 𝐅𝐮𝐥𝐥 𝐈𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧 @ https://www.coherentmarketinsights.com/promo/buynow/78

𝐀𝐛𝐨𝐮𝐭 𝐂𝐨𝐡𝐞𝐫𝐞𝐧𝐭 𝐌𝐚𝐫𝐤𝐞𝐭 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

Mr. Shah
Coherent Market Insights Pvt. Ltd.
+1 206-701-6702
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn
Other